Tag Archives: Patients

FDA Approves Retevmo (selpercatinib) for Patients with Advanced RET-Driven Lung and Thyroid Cancers

FDA Approves Retevmo (selpercatinib) for Patients with Advanced RET-Driven Lung and Thyroid Cancers Print this page INDIANAPOLIS, May 8, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) approved Retevmo™ (selpercatinib, 40 mg & 80 mg capsules), the first therapy specifically indicated for the treatment of adult patients with… Read More »

Obesity New Risk Factor for Young COVID Patients

Jennifer Lighter, MD, NYU Langone Health, New York City. Christopher Petrilli, MD, NYU Langone Health, New York City. Leonardo Seoane, MD, Ochsner Health, New Orleans. Clinical Infectious Diseases: “Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission.” medRxiv: “Factors associated with hospitalization and critical illness among 4,103 patients with… Read More »

FDA Approves Ongentys (opicapone) as an Add-On Treatment for Patients with Parkinson’s Disease Experiencing “Off” Episodes

FDA Approves Ongentys (opicapone) as an Add-On Treatment for Patients with Parkinson’s Disease Experiencing “Off” Episodes Print this page SAN DIEGO – April 27, 2020 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Ongentys (opicapone) 25 mg and 50 mg capsules as an… Read More »